Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol vs PRP vs Combination in Alopecia Areata
NCT05954104Phase 2Completed
- Sponsor
- Egymedicalpedia
- Start
- Jul 2023
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands, Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of calcipotriol and autologous platelet-rich plasma in alopecia areata (4 arms), sponsored by Egymedicalpedia. Primary endpoint: Efficacy of topical calcipotriol and platelet Rich Plasma in Alopecia Areata treatment at 3 months. Started Jul 2023; status: completed.
02
Drugs
calcipotriolautologous platelet-rich plasma
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT05954104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05954104.